The Trump administration’s rescheduling order moved FDA-approved marijuana drug products and certain state-regulated medical marijuana products from Schedule I to Schedule III. But for Americans who grow their own at home, the most basic question, did anything actually change for me?, depends entirely on which cannabis attorney you ask. We asked four. They disagree. On… Keep Reading
On April 23, 2026, the Trump administration moved medical marijuana from Schedule I to Schedule III — the biggest federal cannabis policy shift in decades. It was historic. It was also incomplete. Tens of thousands of Americans remain incarcerated for cannabis offenses that are now legal in most of the country. Advocates say rescheduling without… Keep Reading
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov poll found that 59% of Americans already supported legalizing marijuana use, and 84% supported legalizing it for medical purposes. The public has been ahead of federal policy for a long time. The data makes clear how far Washington still has… Keep Reading
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products regulated under qualifying state medical marijuana licenses from Schedule I to Schedule III under federal law. If you’re trying to understand what that actually means — for dispensaries, patients, cannabis businesses and federal policy — this is the explainer. For… Keep Reading
A $10 million payment tied to a Florida Medicaid settlement moved through the Hope Florida Foundation, into two anti-drug nonprofits, and then into a political committee fighting marijuana legalization. Public filings also show a major funding surge at SAM Action during the same period. The full picture remains incomplete, but the overlap, timing, and money… Keep Reading
The hemp boom moved fast. In the years following the 2018 Farm Bill, thousands of companies rushed into the market chasing the same wave. CBD was everywhere. Oils, gummies, topicals, drinks—if it could hold a label, someone was selling CBD in it. Most brands were focused on scale. Few were thinking about what came next.… Keep Reading
When I first moved back to my home state of New Jersey, I was trying to get a read on what was real and what was noise. This state has momentum, but it also has a cloud of uncertainty surrounding it. Everyone’s “in cannabis.” Everyone’s “launching.” Everyone’s “building community.” Then you show up somewhere and… Keep Reading
